Friday, October 19, 2018
12:00 PM-1:30 PM
New York, NY
Grand Hyatt New York
Uris/Juilliard Room
109 East 42nd Street
New York, NY 10017
Nancy S. Reau, MD
The Richard B. Capps Chair of Hepatology
Professor, Department of Internal Medicine
Division of Digestive Diseases and Nutrition
Rush Medical College
Chief, Section of Hepatology
Associate Director of Organ Transplantation
Rush University Medical Center
Chicago, Illinois
Joanne L. Stone, MD, MSHCDL
Professor, Obstetrics, Gynecology, and Reproductive Science
Director, Division of Maternal-Fetal Medicine
Icahn School of Medicine at Mount Sinai
New York, New York
Jointly provided by Postgraduate Institute for Medicine and Integritas Communications
This activity is supported by an independent educational grant from Gilead Sciences, Inc.
This event is neither sponsored nor endorsed by the American College of Obstetricians and Gynecologists
Target Audience
This activity is intended to educate obstetrics/gynecology (OB/GYN) physicians, physician assistants, nurse practitioners, and nurse midwives on appropriate hepatitis C virus (HCV) screening, testing, and referral practices for their patients.
Educational Objectives
Upon completion of this activity, participants will be better able to:
- Provide proactive HCV screening and confirmatory testing for OB/GYN patients per guidelines from the American Association for the Study of Liver Disease and the Society for Maternal-Fetal Medicine
- Counsel patients on the implications of HCV infection, efficacy and safety of current direct-acting antiviral treatment regimens for chronic HCV infection, and behavioral risk reduction
- Coordinate appropriate referrals and multidisciplinary care for HCV-infected women presenting in OB/GYN practices
Program Description
This educational session is designed to better prepare OB/GYNs to identify patients who should be screened for HCV based on relevant professional society recommendations, appropriately link patients to care, and manage pregnancies of women who have HCV. Expert faculty will provide practical information on HCV screening, confirmatory testing, patient education, and counseling strategies for use within the real-world clinical context of OB/GYN practice. Although HCV affects women across diverse age groups and demographics, pregnancy raises additional considerations and risks for the HCV-infected mother and her unborn child, including mother-to-child-transmission of the virus, for which faculty will share recommendations and management insights.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Integritas Communications. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.
Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Nora Eldasher prior to the live event at neldasher@integritasgrp.com.
Fee Information
There is no fee for this educational activity
Register Now


18
2025
Interleukin-33 and Lower Tract Respiratory Diseases
Moving From Pathophysiology to Management
Time: | 6:30 PM-8:30 PM PT |
Venue: | Marriott Marquis San Francisco, Yerba Buena 7 (Lower B2 Level) |
Location: | San Francisco, CA |
Faculty: | Professor Tom Wilkinson MA Cantab MBBS PhD FRCP FERS; Professor Dave Singh MD, FERS, FBPhS; Jonathan M. Hand, MD |


18
2025
Interleukin-33 and Lower Tract Respiratory Diseases
Moving From Pathophysiology to Management
Time: | 7:00 PM-8:30 PM PT |
Venue: | Live Stream |
Location: | Live Stream |
Faculty: | Jonathan M. Hand, MD; Professor Dave Singh MD, FERS, FBPhS; Professor Tom Wilkinson MA Cantab MBBS PhD FRCP FERS |